about
Discovery and SAR of potent, orally available 2,8-diaryl-quinoxalines as a new class of JAK2 inhibitorsPotent and selective inhibition of polycythemia by the quinoxaline JAK2 inhibitor NVP-BSK805Modulation of Activation-Loop Phosphorylation by JAK Inhibitors Is Binding Mode DependentDiscovery of a Dihydroisoquinolinone Derivative (NVP-CGM097): A Highly Potent and Selective MDM2 Inhibitor Undergoing Phase 1 Clinical Trials in p53wt Tumors
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Carole Pissot-Soldermann
@ast
Carole Pissot-Soldermann
@en
Carole Pissot-Soldermann
@es
Carole Pissot-Soldermann
@nl
Carole Pissot-Soldermann
@sl
type
label
Carole Pissot-Soldermann
@ast
Carole Pissot-Soldermann
@en
Carole Pissot-Soldermann
@es
Carole Pissot-Soldermann
@nl
Carole Pissot-Soldermann
@sl
prefLabel
Carole Pissot-Soldermann
@ast
Carole Pissot-Soldermann
@en
Carole Pissot-Soldermann
@es
Carole Pissot-Soldermann
@nl
Carole Pissot-Soldermann
@sl